Back to search

Italy· 026707036

TUDCABIL*20 cps 250 mg

A medicinal product containing acido tauroursodesossicolico, registered in Italy by BRUSCHETTINI Srl, on the national reimbursement list.

Reimbursed in Italy (AIFA class A)

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedTUDCABIL*20 cps 250 mgATC—REGISTER NO.026707036PACKS LISTED1CHECKEDJune 4, 2026

The record

At a glance

Active substance
Acido tauroursodesossicolico
Manufacturer
BRUSCHETTINI Srl
Country
Italy (IT)
ATC code
—
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    026707036
    TUDCABIL*20 cps 250 mg
    EUR 10.16

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acido tauroursodesossicolico in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acido tauroursodesossicolico products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b8ad4005-87f9-4661-ad6e-79aa254cf2d5
GET /v1/drugs/b8ad4005-87f9-4661-ad6e-79aa254cf2d5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 10.16,
  "source": "aifa",
  "currency": "EUR",
  "strength": "ACIDO TAUROURSODESOSSICOLICO 250MG 20 UNITA' USO ORALE",
  "substance": "Acido tauroursodesossicolico",
  "equivalence_group": "H8B",
  "transparency_flag": null
}

See everything about acido tauroursodesossicolico.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.